ReShape Lifesciences (RSLS) director Blackford received 253,429 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Gary Blackford (director at ReShape Lifesciences Inc., RSLS) reported that they received 253,429 shares on Jul 22, 2021. After these transactions the filing shows 253,429 shares held directly.
- Reporting person
- Blackford Gary
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 22, 2021 | Grant or award (A) | Common Stock, $0.001 par value per share1 | +253,429 | - | - | 253,429 direct |
Holdings before and after
- Common Stock, $0.001 par value per share: 0 to 253,429 direct
Footnotes from the filing
- 1. These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Blackford report in this RSLS Form 4?
Gary Blackford (director at ReShape Lifesciences Inc., RSLS) reported that they received 253,429 shares on Jul 22, 2021. After these transactions the filing shows 253,429 shares held directly.
How many RSLS shares does Blackford hold after this filing?
The filing shows 253,429 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for RSLS
Earlier insider filings at RSLS
- Sep 17, 2021SEC Form 4: Minocherhomjee Arda Phd was granted 253,429 units of Common Stock
- Sep 17, 2021SEC Form 4: Mcdougal Lori Courtney was granted 253,429 units of Common Stock
- Aug 31, 2021SEC Form 4: Stankovich Thomas bought $51,435 worth of Common Stock (15,000 units at $3.43), increasing direct ownership by 85% to 32,613 units
- Aug 24, 2021SEC Form 4 filed by ReShape Lifesciences Inc.
Keep researching RSLS
- RSLS insider tradesEvery buy and sale reported by ReShape Lifesciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
RSLS
ReShape Lifesciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2016
Get push alerts for RSLS
Full RSLS profile on Quantisnow Follow RSLS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time